Showing results (251-260 of 334) with videos related to

Sort By:
Pageof 34
AIDS (London, England)|July 19, 2016
Influence of geographic origin, sex, and HIV transmission group on the outcome of first-line combined antiretroviral therapy in FranceLaure-Amélie de Monteynard, Sophie Matheron, Jacques Gilquin, et al.
BMJ Paediatrics Open|March 5, 2021
Assessment of SARS-CoV-2 infection by Reverse transcription-PCR and serology in the Paris area: a cross-sectional studyRobert Cohen, Camille Jung, Naim Ouldali, et al.
Open Forum Infectious Diseases|July 17, 2015
Hemagglutination Inhibition Antibody Titers as a Correlate of Protection Against Seasonal A/H3N2 Influenza DiseaseAnne Benoit, Jiri Beran, Jeanne-Marie Devaster, et al.
Therapie|December 17, 2023
Controlled human infection trials: Legitimacy and conditions of implementation in FranceAnne-Laure Morin, Emmanuelle Blanc, Armelle Phalipon, et al.
Rheumatology (Oxford, England)|February 7, 2025
Anti-fibroblast and anti-endothelial cell autoantibodies in pulmonary arterial hypertension (PAH) in patients with connective tissue diseases (CTD)Benjamin Thoreau, Arthur Renaud, Philippe Chafey, et al.
Vaccine|January 13, 2009
Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: results of a Phase 2, randomized, double-blind placebo-controlled trialOdile Launay, Christine Sadorge, Nathalie Jolly, et al.
Clinical and Vaccine Immunology : CVI|December 28, 2013
Genetic and antigenic typing of seasonal influenza virus breakthrough cases from a 2008-2009 vaccine efficacy trialSerge Durviaux, John Treanor, Jiri Beran, et al.
The Journal of Infectious Diseases|June 2, 2011
Safety and immunogenicity of a monovalent 2009 influenza A/H1N1v vaccine adjuvanted with AS03A or unadjuvanted in HIV-infected adults: a randomized, controlled trialOdile Launay, Corinne Desaint, Christine Durier, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 13, 2021
Severity of self-reported symptoms and psychological burden 6-months after hospital admission for COVID-19: a prospective cohort studyPhilippine Eloy, Coralie Tardivon, Guillaume Martin-Blondel, et al.
Nature Communications|November 5, 2025
Safety and immunogenicity of PPV-06, an active anti-IL-6 immunotherapy targeting low-grade inflammation against knee osteoarthritis: a randomized, double-blind, placebo-controlled, clinical phase 1 studyFrançois Rannou, Lucille Desallais, Christelle Nguyen, et al.
Pageof 34